Skip to content

Fortune on Allcyte

Posted on March 25, 2021December 9, 2025 by snijderlab.org

How cool, Fortune Magazine has written a piece on our spinoff company Allcyte. Allcyte uses and develops the Pharmacoscopy platform to bring tailored treatments to each cancer patient.

This startup has found a way to uncover bespoke cancer therapies https://t.co/T7zdxoHbOJ

— Berend Snijder (@BerendSnijder) March 25, 2021
Posted in Company, News

Post navigation

Previous Post Introducing the Tumor Profiler
Next Post @snijderlab on Twitter

Recent Posts

  • Christmas 2025 December 21, 2025
  • NZZ ❤️ PCY December 9, 2025
  • Precision Medicine Award🏅 October 2, 2025
  • 🚀 Prevision Medicine August 19, 2025
  • Berend wins Jucker Prize🏅 June 8, 2025
  • TuPro @ Nature Medicine June 3, 2025
  • Ben wins ETH Medal 🥇 May 25, 2025
  • Snijder Lab → BIIE March 27, 2025
  • 🚀Graph Therapeutics January 9, 2025
  • GBM @ Nature Medicine September 26, 2024

Archives

  • December 2025(2)
  • October 2025(1)
  • August 2025(1)
  • June 2025(2)
  • May 2025(1)
  • March 2025(1)
  • January 2025(1)
  • September 2024(1)
  • August 2024(1)
  • June 2024(1)
  • October 2023(1)
  • July 2023(1)
  • April 2023(1)
  • November 2022(2)
  • August 2022(1)
  • February 2022(1)
  • July 2021(1)
  • April 2021(1)
  • March 2021(1)
  • January 2021(1)
  • November 2020(1)
  • September 2020(1)
  • July 2020(3)
  • June 2020(2)
  • February 2020(1)
  • January 2020(1)
  • December 2019(2)
  • November 2019(1)
  • October 2019(1)
  • May 2019(1)
  • March 2019(1)
  • November 2018(2)
  • October 2018(1)
  • July 2018(1)
  • November 2017(1)
  • August 2017(1)
  • March 2017(1)
  • September 2016(1)